Browse
Submit Data
Databases
API
Help

Dataset Information

3 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Risk factors of intestinal complications after colorectal surgery

ABSTRACT: Interventions: Case series:Nil Primary outcome(s): Intestinal complications Study Design: Case series

DISEASE(S): Colorectal Cancer

PROVIDER: 2680417 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Study for the difference of intestinal microbiota between gastric tumor and intestinal tumor after intestinal preparation and its relationship with postoperative delirium

Project description:Interventions: Case series:Nil Primary outcome(s): intestinal flora;postoperative delirium Study Design: Cohort study

| 2680198 | ecrin-mdr-crc

Relevance study and prognostic analysis for intestinal flora disorders affecting non-coding RNA networks in patients with advanced lung cancer

Project description:Interventions: Case series:Nil Primary outcome(s): intestinal microecological disorders;blood non-coding RNAs and immune status Study Design: Randomized parallel controlled trial

| 2681498 | ecrin-mdr-crc

Risk factors for wound complications following spine surgery.

Project description: Not available

| S-EPMC5682694 | biostudies-other

Risk factors for cardiac complications after spine surgery.

Project description: Not available

| S-EPMC3623101 | biostudies-other

Risk factors for pulmonary complications after spine surgery.

Project description: Not available

| S-EPMC3623103 | biostudies-other

Changes of intestinal microbiota before and after operation in patients with colon cancer and its influencing factors

Project description:Interventions: Case series:operation Primary outcome(s): Intestinal flora Study Design: Randomized parallel controlled trial

| 2678001 | ecrin-mdr-crc

Predictive modeling of risk factors and complications of cataract surgery.

Project description: Not available

| S-EPMC4930873 | biostudies-literature

The utility of circulating tumor DNA as a prognostic biomarker of radical surgery for metastatic colorectal cancer

Project description:Interventions: Case series:Nil Primary outcome(s): Allelic frequency of ctDNA Study Design: Case series

| 2678167 | ecrin-mdr-crc

The effect of preoperative Intestinal microbiota dysbiosis on postoperative recovery of gastrointestinal cancer patients

Project description:Interventions: Case series:Nil Primary outcome(s): Diarrhea Study Design: Cohort study

| 2679924 | ecrin-mdr-crc

5-Hydroxymethylcytosines in Circulating Cell-free DNA Reveal Vascular Complications of Type 2 Diabetes

Project description:BACKGROUND: Long-term complications of type 2 diabetes (T2D), such as macrovascular and microvascular events, are the major causes for T2D-related disability and mortality. A clinically convenient, non-invasive approach for monitoring the development of these complications would improve the overall life quality of patients with T2D and help reduce healthcare burden through preventive interventions. METHODS: A selective chemical labeling strategy for 5-hydroxymethylcytosines (5hmC-Seal) was used to profile genome-wide 5hmCs, an emerging class of epigenetic markers implicated in complex diseases including diabetes, in circulating cell-free DNA (cfDNA) from a collection of Chinese patients (n = 62). Differentially modified 5hmC markers between patients with T2D with and without macrovascular/microvascular complications were analyzed under a case-control design. RESULTS: Statistically significant changes in 5hmC markers were associated with T2D-related macrovascular/microvascular complications, involving genes and pathways relevant to vascular biology and diabetes, including insulin resistance and inflammation. A 16-gene 5hmC marker panel accurately distinguished patients with vascular complications from those without (testing set: AUC = 0.85, 95%CI, 0.73-0.96), outperforming conventional clinical variables such as urinary albumin. In addition, a separate 13-gene 5hmC marker panel could distinguish patients with single complications from those with multiple complications (testing set: AUC = 0.84, 95%CI, 0.68-0.99), showing superiority over conventional clinical variables. CONCLUSIONS: The 5hmC markers in cfDNA reflected the epigenetic changes in patients with T2D who developed macrovascular/microvascular complications. The 5hmC-Seal assay has the potential to be a clinically convenient, non-invasive approach that can be applied in the clinic to monitor the presence and severity of diabetic vascular complications.

2020-01-31 | GSE125929 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data